Calcium-ion-modulated ceramic hydroxyapatite resin for the scalable purification of recombinant Adeno-Associated Virus serotype 9

被引:6
作者
Qu, Weihong [1 ,2 ,4 ]
Wang, Mingxi [1 ,2 ,3 ]
Wu, Yaqing [1 ,2 ,3 ]
Lv, Yinghui [1 ,2 ,3 ]
Wang, Qizhao [1 ,2 ,3 ]
Xu, Ruian [1 ,2 ,3 ]
机构
[1] Huaqiao Univ, Sch Med, Quanzhou 361021, Fujian, Peoples R China
[2] Huaqiao Univ, Inst Mol Med, Quanzhou 361021, Fujian, Peoples R China
[3] Minist Educ, Engn Res Ctr Mol Med, Xiamen 361021, Fujian, Peoples R China
[4] Jiujiang Univ, Coll Med & Life Sci, Jiujiang 332000, Jiangxi, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2015年 / 990卷
基金
中国国家自然科学基金;
关键词
Calcium ion; Ceramic hydroxyapatite resin; Scalable purification; rAAV9; MANUFACTURING PRACTICE PRODUCTION; GENE-TRANSFER; ALIPOGENE TIPARVOVEC; ADENOVIRAL VECTORS; IMMUNE-RESPONSES; KALLISTATIN; HEMOPHILIA; ANGIOGENESIS; EXCHANGE; THERAPY;
D O I
10.1016/j.jchromb.2015.03.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Column chromatography has been widely used as a scalable purification strategy for recombinant adeno-associated virus (rAAV) vectors. The rAAV1, 2, 4, 5, 6, 8 and 9 serotypes could be separated using affinity resins, ion exchange resins or other types of resins. Apatite resin has displayed outstanding performance in protein purification in the past 10 years, and ceramic hydroxyapatite (CHT) chromatography resin with a polyethylene glycol (PEG) modulation has recently been used for rAAV1 and rAAV9 vectors. This study reports the use of CHT chromatography modulated by calcium ions instead of PEG for rAAV9 purification. Calcium-ion-containing buffers effectively improve the inclusion of CHT as a capture resin, the resin-binding capacity and the yield. The optimum calcium ion concentration is 30 ppm, and the optimum pH is 7.0. A frontal analysis indicated that the binding capacity of CHT at 2 ml/min reaches 65.1 mg total protein per ml of resin. A previously developed purification strategy consists of CHT followed by ANX anion exchange chromatography. The vector yield of this approach is approximately 70%, and a software analysis indicated a vector purity exceeding 98%. The residual host cell (HEK293) protein contents are 24.75 +/- 2.32 ng and 67.21 +/- 2.10 ng, and the Benzonase residue contents are 1.55 +/- 0.10 pg and 1.95 +/- 0.16 ng per 1013 vector genome copies (G.C.) separated by CHT/ANX and CsCl. In addition, CHT/ANX yields 798.44 +/- 50.10 pg of plasmid DNA and 2.17 +/- 0.11 ng of HEK293 DNA, while CsCI purification yields 840.27 +/- 76.14 pg of plasmid DNA and 2.43 +/- 0.19 of HEK293 DNA. The two methods produce vectors with similar in vitro and in vivo potencies. The results indicated that the CHT/ANX method is suitable for the scalable purification of the rAAV9 vector. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 48 条
  • [31] A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype
    Ellis, Brian L.
    Hirsch, Matthew L.
    Barker, Jenny C.
    Connelly, Jon P.
    Steininger, Robert J., III
    Porteus, Matthew H.
    VIROLOGY JOURNAL, 2013, 10
  • [32] Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction
    Naumer, Matthias
    Popa-Wagner, Ruth
    Kleinschmidt, Juergen A.
    JOURNAL OF GENERAL VIROLOGY, 2012, 93 : 2131 - 2141
  • [33] EDC/NHS-mediated heparinization of small intestinal submucosa for recombinant adeno-associated virus serotype 2 binding and transduction
    Yue, Tse-Wei
    Chien, Wei-Che
    Tseng, S. -Ja
    Tang, Shiue-Cheng
    BIOMATERIALS, 2007, 28 (14) : 2350 - 2357
  • [34] Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2/9
    Stitelman, David H.
    Brazelton, Tim
    Bora, Archana
    Traas, Jeremy
    Merianos, Demetri
    Limberis, Maria
    Davey, Marcus
    Flake, Alan W.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2014, 1 : 14040
  • [35] Development of Recombinant Adeno-Associated Virus Serotype 2/8 Carrying Kringle Domains of Human Plasminogen for Sustained Expression and Cancer Therapy
    Kuo, Cheng-Hsiang
    Chang, Bi-Ing
    Lee, Fang-Tzu
    Chen, Po-Ku
    Lee, Jeng-Shin
    Shi, Guey-Yueh
    Wu, Hua-Lin
    HUMAN GENE THERAPY, 2015, 26 (09) : 603 - 613
  • [36] Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus Monkeys
    Hordeaux, Juliette
    Hinderer, Christian
    Buza, Elizabeth L.
    Louboutin, Jean-Pierre
    Jahan, Tahsin
    Bell, Peter
    Chichester, Jessica A.
    Tarantal, Alice F.
    Wilson, James M.
    HUMAN GENE THERAPY, 2019, 30 (08) : 957 - 966
  • [37] Attenuation of Monocrotaline-Induced Pulmonary Hypertension by Luminal Adeno-Associated Virus Serotype 9 Gene Transfer of Prostacyclin Synthase
    Gubrij, Igor B.
    Martin, Sara Rebecca
    Pangle, Amanda K.
    Kurten, Richard
    Johnson, Larry G.
    HUMAN GENE THERAPY, 2014, 25 (06) : 498 - 505
  • [38] Universal Gene Correction Approaches for β-hemoglobinopathies Using CRISPR-Cas9 and Adeno-Associated Virus Serotype 6 Donor Templates
    Lamsfus-Calle, Andres
    Daniel-Moreno, Alberto
    Urena-Bailen, Guillermo
    Rottenberger, Jennifer
    Raju, Janani
    Epting, Thomas
    Marciano, Sabina
    Heumos, Lukas
    Baskaran, Praveen
    Antony, Justin S.
    Handgretinger, Rupert
    Mezger, Markus
    CRISPR JOURNAL, 2021, 4 (02): : 207 - 222
  • [39] A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity
    Chamberlain, Kyle
    Riyad, Jalish M.
    Garnett, Tyrone
    Kohlbrenner, Erik
    Mookerjee, Ananda
    Elmastour, Firas
    Benard, Ludovic
    Chen, Jiqiu
    VandenDriessche, Thierry
    Chuah, Marinee K.
    Marian, Ali J.
    Hajjar, Roger J.
    Gurha, Priyatansh
    Weber, Thomas
    HUMAN GENE THERAPY, 2018, 29 (08) : 927 - 937
  • [40] Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle
    Evans, Vanessa C.
    Graham, Ian R.
    Athanasopoulos, Takis
    Galley, Deborah J.
    Jackson, Christopher L.
    Simons, Jonathan Paul
    Dickson, George
    Owen, James S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (04): : 491 - 498